» Articles » PMID: 29635745

The Design and Rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia

Abstract

Atherosclerotic cardiovascular disease (ASCVD) is highly heritable, particularly when it occurs at a young age. The screening of individuals with premature ASCVD, although often recommended, is not routinely performed. Strategies to address this gap in care are essential. We designed the Study to Avoid CardioVascular Events in British Columbia (SAVE BC) as a prospective, observational study of individuals with a new diagnosis of very premature ASCVD (defined as age ≤ 50 years in males and age ≤ 55 years in females) and their first-degree relatives (FDRs) and spouses. FDRs and spouses will undergo screening for cardiovascular (CV) risk factors and subclinical ASCVD using a structured screening algorithm. All subjects will be followed longitudinally for ≥10 years. The overall goal of SAVE BC is to evaluate the yield of a structured screening program for identifying individuals at risk of premature ASCVD. The primary objectives of SAVE BC are to identify and follow index cases with very premature ASCVD and their FDRs and to determine the diagnostic yield of a structured screening program for these individuals. We will collect data on CV risk factors, medication use, CV events, and healthcare costs in these individuals. SAVE BC will provide insight regarding approaches to identify individuals at risk for premature ASCVD with implications for prevention and treatment in this population.

Citing Articles

Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease.

Vikulova D, Lee M, Humphries K, Pinheiro-Muller D, Dawes M, Pimstone S JACC Adv. 2025; 4(1):101316.

PMID: 39811754 PMC: 11730227. DOI: 10.1016/j.jacadv.2024.101316.


Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease.

Vikulova D, Pinheiro-Muller D, Francis G, Halperin F, Sedlak T, Walley K Am J Prev Cardiol. 2024; 19:100704.

PMID: 39076574 PMC: 11284940. DOI: 10.1016/j.ajpc.2024.100704.


The Importance of Nontraditional and Sex-Specific Risk Factors in Young Women With Vasomotor Nonobstructive vs Obstructive Coronary Syndromes.

Theberge E, Vikulova D, Pimstone S, Brunham L, Humphries K, Sedlak T CJC Open. 2024; 6(2Part B):279-291.

PMID: 38487074 PMC: 10935675. DOI: 10.1016/j.cjco.2023.08.012.


Identification and treatment of those most at risk for premature atherosclerotic cardiovascular disease: We just cannot seem to get it right.

Toth P Am J Prev Cardiol. 2021; 2:100040.

PMID: 34327461 PMC: 8315455. DOI: 10.1016/j.ajpc.2020.100040.


Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation.

Vikulova D, Skorniakov I, Bitoiu B, Brown C, Theberge E, Fordyce C Am J Prev Cardiol. 2021; 2:100036.

PMID: 34327459 PMC: 8315606. DOI: 10.1016/j.ajpc.2020.100036.


References
1.
. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

2.
Wiegman A, Gidding S, Watts G, Chapman M, Ginsberg H, Cuchel M . Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015; 36(36):2425-37. PMC: 4576143. DOI: 10.1093/eurheartj/ehv157. View

3.
Domanski M, Fuster V, Diaz-Mitoma F, Grundy S, Lloyd-Jones D, Mamdani M . Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial. J Am Coll Cardiol. 2015; 66(16):1828-1836. DOI: 10.1016/j.jacc.2015.08.857. View

4.
Schaefer E, Genest Jr J, Ordovas J, Salem D, Wilson P . Familial lipoprotein disorders and premature coronary artery disease. Atherosclerosis. 1994; 108 Suppl:S41-54. DOI: 10.1016/0021-9150(94)90152-x. View

5.
Lloyd-Jones D, Nam B, DAgostino Sr R, Levy D, Murabito J, Wang T . Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004; 291(18):2204-11. DOI: 10.1001/jama.291.18.2204. View